Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation
Organic Letters · 17.05.2024 · 26 (19) · 4059-4064
DOI: 10.1021/acs.orglett.4c00982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Organic Letters, online erschienen am 06.05.2024. Verfasst von Diane N Le und 5 weiteren Autor:innen. Beteiligte Einrichtung: Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
- Modeling and Informatics, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
- Chemistry Service Unit, WuXi AppTec (Tianjin), Tianjin 300457, China.
ORCID-Profile: Diane N Le, Heather C Johnson, Yu-Hong Lam, Kevin M Belyk
Zitieren
APA
Le, D. N., Johnson, H. C., Lam, Y. H., Sun, C., Cheng, L., & Belyk, K. M. (2024). Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation. Organic Letters, 26(19), 4059-4064. https://doi.org/10.1021/acs.orglett.4c00982
Vancouver
Le DN, Johnson HC, Lam YH, Sun C, Cheng L, Belyk KM. Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation. Organic Letters. 2024;26(19):4059-4064. doi:10.1021/acs.orglett.4c00982
BibTeX
@article{Le2024,
author = {Le, Diane N and Johnson, Heather C and Lam, Yu-Hong and Sun, Chunrui and Cheng, Lili and Belyk, Kevin M},
title = {Enantio- and Diastereoselective Total Synthesis of Belzutifan Enabled by Rh-Catalyzed Hydrogenation},
journal = {Organic Letters},
year = {2024},
volume = {26},
number = {19},
pages = {4059--4064},
doi = {10.1021/acs.orglett.4c00982}
}
EUVIMED